Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.
Brenner JS, Bhamidipati K, Glassman PM, Ramakrishnan N, Jiang D, Paris AJ, Myerson JW, Pan DC, Shuvaev VV, Villa CH, Hood ED, Kiseleva R, Greineder CF, Radhakrishnan R, Muzykantov VR.
Brenner JS, et al. Among authors: muzykantov vr.
Nanomedicine. 2017 May;13(4):1495-1506. doi: 10.1016/j.nano.2016.12.019. Epub 2017 Jan 5.
Nanomedicine. 2017.
PMID: 28065731
Free PMC article.